High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.
The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.
Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.
Beyond analysts' top-and-bottom-line estimates for UnitedHealth (UNH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
MU, UNH and SJM highlight recent gains across Zacks portfolios as the firm showcases performance amid mixed markets.
News of the day for July 13, 2026
In July 2026, Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for eligible UnitedHealth Group members aged 45 and over, extending access to this noninvasive option across roughly 40 million people in employer, individual and Medicare-related plans amid rising colorectal cancer rates in younger adults. This move highlights UnitedHealth Group’s role in broadening access to newer cancer screening technologies, potentially reshaping how its...
Buffett originally bought shares of the health insurance giant last year.
After a rocky start to the year, health insurer stocks have roared back. The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic. The fund’s top 10 holdings encompass six health insurers, three of which— UnitedHealth Group Aetna parent CVS Health and Elevance Health —comprise more than 40% of the fund.
Big banks kick off earnings season this week, which will also bring reports from GE Aerospace, Netflix, and Taiwan Semi. In economic news, we’ll get the consumer and producer price indexes, and retail sales data.
The big banks dominate this week's reporting docket, though several notable companies from other sectors will also report, including Netflix, Johnson & Johnson, and others. With the outlook trending consistently higher, will companies be able to live up to expectations?
The latest trading day saw UnitedHealth Group (UNH) settling at $424.62, representing a -1.64% change from its previous close.
Taiwan Semi, Goldman and GE Aerospace are big earnings due with the market improving. Nvidia, Sandisk, Micron, Robinhood are near buy points.
Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.
UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.
The Iran war and a tug-of-war between AI stocks and other parts of the market have left the S&P 500 stuck in a range. On Friday, the S&P 500’s healthcare sector was the only major sector trading down more than 0.1%: It was down 0.7%. Moderna was the S&P’s biggest laggard, while UnitedHealth was the big drag on the Dow.
U. S. stock futures traded little changed on Friday as investors paused after Thursday’s technology-led rally, shifting their attention toward next week’s corporate earnings reports and key inflation releases.
The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.
UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16
UnitedHealth Group (UNH) is back in focus after raising earnings guidance, tightening cost controls and benefiting from higher Medicare Advantage plan rates, with investors watching closely ahead of the upcoming Q2 results. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s share price has picked up momentum, with a 4.52% 1 month share price return and a 41.85% 3 month share price return. The 1 year total shareholder return of 47.99% reflects a strong recovery story that...
Earnings optimism, AI demand, and healthcare momentum drove gains.
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.
The health insurer's stock price is up 61% since April.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
